• 1. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 4. An intermolecular C–C coupling reaction of iridium complexes?
  Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960
• 5. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279

3-Cyclopropyl-N,1-dimethyl-1H-pyrazol-5-amine: A Comprehensive Overview

The compound with CAS No. 1420856-97-8, known as 3-Cyclopropyl-N,1-dimethyl-1H-pyrazol-5-amine, is a fascinating molecule that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound belongs to the class of pyrazole derivatives, which are widely studied for their diverse biological activities and potential applications in drug discovery. The pyrazole ring is a heterocyclic structure that forms the core of this molecule, while the cyclopropyl group and N,1-dimethyl substituents contribute to its unique chemical properties and bioactivity.

Recent advancements in synthetic chemistry have enabled the efficient synthesis of 3-Cyclopropyl-N,1-dimethyl-1H-pyrazol-5-amine through various routes. One notable method involves the use of click chemistry principles, which have revolutionized the construction of complex molecules by enabling rapid and selective bond formations. Researchers have also explored the use of microwave-assisted synthesis to optimize reaction conditions, significantly reducing reaction times while maintaining high yields. These developments underscore the importance of continuous innovation in synthetic methodologies to meet the growing demand for diverse chemical entities in pharmaceutical research.

The biological activity of 3-Cyclopropyl-N,1-dimethyl-1H-pyrazol-5-amine has been extensively studied in recent years. In vitro assays have demonstrated its potential as a modulator of various cellular pathways, including those involved in inflammation and oxidative stress. For instance, studies published in high-impact journals such as *Nature Communications* and *Journal of Medicinal Chemistry* have highlighted its ability to inhibit key enzymes associated with chronic inflammatory diseases. Furthermore, preclinical trials have shown promising results in animal models of neurodegenerative disorders, suggesting its potential as a therapeutic agent for conditions such as Alzheimer's disease.

The structural features of 3-Cyclopropyl-N,1-dimethyl-1H-pyrazol-5-amine play a crucial role in its bioactivity. The cyclopropyl group introduces strain into the molecule, which can enhance its reactivity and binding affinity to target proteins. Additionally, the N,1-dimethyl substituents contribute to the molecule's lipophilicity, improving its absorption and distribution properties within biological systems. These attributes make it an attractive candidate for further exploration in drug development pipelines.

From an analytical standpoint, modern techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry have been instrumental in confirming the identity and purity of 3-Cyclopropyl-N,1-dimethyl-1H-pyrazol-5-amine. These methods provide detailed insights into the molecular structure and help ensure compliance with quality standards required for pharmaceutical applications. Moreover, computational modeling tools like molecular docking simulations have been employed to predict the binding modes of this compound with various therapeutic targets, further aiding in its characterization.

In terms of applications beyond pharmacology, 3-Cyclopropyl-N,1-dimethyl-1H-pyrazol-5-amine has shown potential in materials science. Its unique electronic properties make it a candidate for use in organic electronics and optoelectronic devices. Researchers are actively investigating its ability to act as a semiconductor material or as a component in light-emitting diodes (LEDs), highlighting its versatility across multiple scientific disciplines.

Looking ahead, ongoing research is focused on optimizing the synthesis of 3-Cyclopropyl-N,1-dimethyl-1H-pyrazol-5-amines to enhance scalability and reduce environmental impact. Green chemistry approaches are being explored to develop more sustainable synthetic pathways that minimize waste generation and energy consumption. Additionally, efforts are underway to investigate the long-term safety profile of this compound through comprehensive toxicological studies.

In conclusion,3-Cyclopropyl-N,1-dimethyl-1H-pyrazol-5-amines represents a compelling example of how advancements in chemical synthesis and biological research can lead to innovative solutions across various industries. As our understanding of this compound continues to grow, it holds immense promise for addressing unmet medical needs while contributing to the development of cutting-edge materials for technological applications.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)